Usefulness of Contrast-Enhanced T1-Weighted Sampling Perfection with Application-Optimized Contrasts by Using Different Flip Angle Evolutions in Detection of Small Brain Metastasis at 3T MR Imaging: Comparison with Magnetization-Prepared Rapid Acquisition of Gradient Echo Imaging

References

1. ↵
   Sills AK. Current treatment approaches to surgery for brain metastases. Neurosurgery 2005 :57 (5 suppl):S24–32, discussion S1–4

   PubMed
2. ↵
   Chang EL, Hassenbusch SJ 3rd, Shiu AS, et al. The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery 2003;53:272–80

   CrossRefPubMed
3. ↵
   Chappell PM, Pelc NJ, Foo TK, et al. Comparison of lesion enhancement on spin-echo and gradient-echo images. AJNR Am J Neuroradiol 1994;15:37–44

   Abstract/FREE Full Text
4. ↵
   Wenz F, Hess T, Knopp MV, et al. 3D MPRAGE evaluation of lesions in the posterior cranial fossa. Magn Reson Imaging 1994;12:553–58

   CrossRefPubMed
5. ↵
   Runge VM, Patel MC, Baumann SS, et al. T1-weighted imaging of the brain at 3 Tesla using a 2-dimensional spoiled gradient echo technique. Invest Radiol 2006;41:68–75

   CrossRefPubMed
6. ↵
   Schwindt W, Kugel H, Bachmann R, et al. Magnetic resonance imaging protocols for examination of the neurocranium at 3T. Eur Radiol 2003;13:2170–79

   CrossRefPubMed
7. ↵
   Kakeda S, Korogi Y, Hiai Y, et al. Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences. Eur Radiol 2007;17:2345–51

   CrossRefPubMed
8. ↵
   Furutani K, Harada M, Mawlan M, et al. Difference in enhancement between spin echo and 3-dimensional fast spoiled gradient recalled acquisition in steady state magnetic resonance imaging of brain metastasis at 3-T magnetic resonance imaging. J Comput Assist Tomogr 2008;32:313–19

   CrossRefPubMed
9. ↵
   Mugler JP 3rd, Bao S, Mulkern RV, et al. Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology 2000;216:891–99

   CrossRefPubMedWeb of Science
10. ↵
    Schörner W, Laniado M, Niendorf HP, et al. Time dependent changes in image contrast in brain tumors after gadolinium-DTPA. AJNR Am J Neuroradiol 1986;7:1013–20

    Abstract/FREE Full Text
11. ↵
    Young RF. Radiosurgery for the treatment of brain metastases. Semin Surg Oncol 1998;14:70–78

    CrossRefPubMed
12. ↵
    Namba Y, Kijima T, Yokota S, et al. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 2004;6:123–28

    PubMed
13. ↵
    Rand S, Maravilla KR Schmiedl U. Lesion enhancement in radio-frequency spoiled gradient-echo imaging: theory, experimental evaluation, and clinical implications. AJNR Am J Neuroradiol 1994;15:27–35

    Abstract/FREE Full Text
14. ↵
    Yuh WT, Tali ET, Nguyen HD, et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995;16:373–80

    Abstract/FREE Full Text
15. ↵
    Kurt Rossmann Laboratories for Radiologic Image Research. The University of Chicago Department of Radiology (2007). ROC SOFTWARE. Available at: http://www-radiology.uchicago.edu/krl/roc_soft6.htm. Accessed February 29,2008
16. ↵
    Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis: generalization to the population of readers and patients with the jackknife method. Invest Radiol 1992;27:723–31

    CrossRefPubMedWeb of Science
17. ↵
    Komada T, Naganawa S, Ogawa H, et al. Contrast-enhanced MR imaging of metastatic brain tumor at 3 Tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence Magn Reson Med Sci 2008;7:13–21

    CrossRefPubMed
18. ↵
    Mugler JP 3rd, Brookeman JR. Theoretical analysis of gadopentetate dimeglumine enhancement in T1-weighted imaging of the brain: comparison of two-dimensional spin-echo and three-dimensional gradient-echo sequences. J Magn Reson Imaging 1993;3:761–69

    CrossRefPubMed
19. ↵
    Fishbach F, Bruhn H, Pech M, et al. Efficacy of contrast medium use for neuroimaging at 3.0T: utility of IR-FSE compared to other T1-weighted pulse sequences. J Comput Assist Tomogr 2005;29:499–505

    CrossRefPubMed
20. ↵
    Constable RT, Anderson AW, Zhong J, et al. Factors influencing contrast in fast spin-echo MR imaging. Magn Reson Imaging 1992;10:497–511

    CrossRefPubMed
21. ↵
    Runge VM, Wells JW, Nelson KL, et al. MR imaging detection of cerebral metastases with a single injection of high-dose gadoteridol. J Magn Reson Imaging 1994;4:669–73

    PubMed
22. ↵
    Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K, et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 2003;38:415–22

    CrossRefPubMedWeb of Science
23. ↵
    Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;26:1190–97

    CrossRefPubMedWeb of Science